Jeronimo Martins: Recent Correction Is A Buying Opportunity

Jeronimo Martins is seen as undervalued after a 13% YTD share price decline despite robust revenue and EBITDA growth. Recent margin compression in Poland and Portugal is described as likely cyclical rather than structural, while faster-growing Colombian unit Ara could be worth significantly more if spun off. The note is constructive on fundamentals and valuation, but it is an analyst-style view rather than a major new corporate event.

Analysis

The market is likely extrapolating near-term margin pressure into a structural reset, which is usually the wrong response for a retailer with recurring consumer demand and improving top-line momentum. If the earnings gap is mostly mix, wage, and input-driven in Poland and Portugal, then the first derivative to watch is not headline margin recovery but whether pricing and volume discipline stay intact through the next 1-2 quarters. In that setup, the stock can rerate before the P&L fully inflects, because investors tend to pay for proof that the margin trough is temporary rather than waiting for full normalization.

Ara is the underappreciated optionality: a faster-growing LATAM asset inside a mature European footprint can create a sum-of-the-parts discount if left embedded, especially if the market is applying a blended multiple to the whole company. A spin or partial monetization would likely force investors to value the Colombia business off growth and regional scarcity rather than grocery-retail averages, which can materially lift implied equity value even without operational change. The second-order effect is that management may have more room for capital recycling into the highest-return geographies, which could improve consolidated ROIC and narrow the valuation gap over 6-18 months.

Consensus seems to be pricing in a prolonged earnings reset, but the more likely path is uneven but recoverable margin normalization with upside from operating leverage if consumer demand holds. The risk case is that Poland remains promotional longer than expected or Portugal fails to recover volume after price actions, turning a cyclical dip into a multi-year share loss. The key catalyst window is the next two reporting cycles: if margins stabilize rather than rebound, the market can start underwriting reacceleration; if not, the de-rating remains justified. The asymmetric opportunity is that a modest multiple re-rating on unchanged earnings can do more for the stock than waiting for full profit recovery.

Key Decisions for Investors

• Initiate a medium-term long in Jeronimo Martins on weakness, sized for a 6-12 month horizon, targeting a rerating once the market accepts that margin compression is cyclical rather than structural; use a 15-20% downside stop if subsequent quarters show continued gross margin deterioration.
• Prefer a call spread or risk-defined upside structure over cash equity if available, capturing the possibility of a re-rating from margin stabilization and Ara optionality with limited capital at risk over the next 3-6 months.
• If liquidity allows, build the position ahead of the next earnings print rather than after it; the setup favors a sentiment inflection on any evidence of stable volumes and sequential margin improvement.
• Use any announcement or credible speculation around Ara separation as a catalyst to add; that event could unlock a sum-of-the-parts uplift that the market is currently not capitalizing into the parent.
• Avoid shorting comparable defensive grocers on this thesis alone; the better expression is long JM against a basket of slower-growth European staples if you want to isolate re-rating potential from sector beta.